About Asa Rén
Asa Rén is a company based in Jakarta (Indonesia) founded in 2020. Asa Rén has raised $8.15 million across 1 funding round from investors including Diagnos Laboratorium Utama, Top Harvest Capital and Kejora Capital. Asa Rén offers products and services including AsaX App and AI-assisted Platform. Asa Rén operates in a competitive market with competitors including DNAandMe and BioElitics, among others.
- Headquarter Jakarta, Indonesia
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Asa Ren Pte Ltd
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$8.15 M (USD)
in 1 rounds
-
Latest Funding Round
$8.15 M (USD), Seed
Feb 01, 2023
-
Investors
Diagnos Laboratorium Utama
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Asa Rén
Asa Rén offers a comprehensive portfolio of products and services, including AsaX App and AI-assisted Platform.
App for personalized healthcare using clinico-genomic data and real-time insights.
Platform for health data analysis and personalized treatment recommendations.
Funding Insights of Asa Rén
Asa Rén has successfully raised a total of $8.15M through 1 strategic funding round. The most recent funding activity was a Seed round of $8.15 million completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $8.2M
-
First Round
First Round
(01 Feb 2023)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2023 | Amount | Seed - Asa Rén | Valuation | Top Harvest Capital , Kejora Capital |
Investors in Asa Rén
Asa Rén has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Diagnos Laboratorium Utama, Top Harvest Capital and Kejora Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in consumer businesses
|
Founded Year | Domain | Location |
Investments & Acquisitions by Asa Rén
Financial Statements - Asa Rén
Asa Rén Comparisons
Competitors of Asa Rén
Asa Rén operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DNAandMe and BioElitics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provides genetic testing for diet, health risks, and personal traits analysis.
|
|
| domain | founded_year | HQ Location |
Provides DNA analysis services to identify hereditary diseases.
|
Frequently Asked Questions about Asa Rén
Asa Rén was founded in 2020 and raised its 1st funding round 3 years after it was founded.
Asa Rén is headquartered in Jakarta, Indonesia. It is registered at Jakarta, Jakarta, Indonesia.
Asa Rén is a funded company, having raised a total of $8.15M across 1 funding round to date. The company's 1st funding round was a Seed of $8.15M, raised on Feb 01, 2023.
Founded in 2020 and based in Jakarta, Indonesia, an AI-powered platform is developed by Asa Rén for precision medicine and longevity research. Services are provided to healthcare providers, synthetic life and data science entities, and individuals. Personalized treatments are advanced, treatment and medicine performance is predicted, and life-saving technologies are discovered. Impact is created across health segments to support a unified ecosystem in the healthcare sector.
Asa Rén's top competitors include DNAandMe and BioElitics.
Asa Rén offers AsaX App and AI-assisted Platform.
Asa Rén has 6 investors. Key investors include Diagnos Laboratorium Utama, Top Harvest Capital, Kejora Capital, Marcy Venture Partners, and Northstar Group.